Table 3 Clinical results obtained in the outpatient assessment.
From: Prevalence of post-intensive care syndrome in mechanically ventilated patients with COVID-19
N = 186 | |
|---|---|
Dyspnea, (mMRC), n (%) | |
0 | 80 (43) |
1 | 57 (31) |
2 | 29 (15) |
3 | 17 (9) |
4 | 3 (2) |
Muscular weakness, n (%) | 91 (49) |
Joint pain, n (%) | 83 (45) |
Joint limitation, n (%) | 53 (28) |
Paraesthesia, n (%) | 45 (24) |
Alopecia, n (%) | 42 (23) |
Anosmia, n (%) | 21 (11) |
Headache, n (%) | 18 (10) |
Dysphagia, n (%) | 5 (3) |
SF-12 score | |
- Physical | |
--Physical function, mean (SD) | 41 (12) |
--Role physical, mean (SD) | 44 (12) |
--Bodily pain, mean (SD) | 40 (13) |
--General health, mean (SD) | 38 (11) |
- Mental | |
--Vitality, mean (SD) | 48 (12) |
--Social functioning, mean (SD) | 47 (12) |
--Role emotional, mean (SD) | 42 (13) |
--Mental health, mean (SD) | 49 (10) |
- Summary | |
--Physical component summary score, mean (SD) | 38 (13) |
--Mental component summary score, mean (SD) | 49 (12) |
Barthel index, mean (SD) | 95 (11) |
MoCA test, mean (SD) | 25 (4) |
HADS-A mean (SD) | 6 (5) |
HADS-D mean (SD) | 5 (4) |
FEV1 mean, % pred. (SD) | 88 (18)* |
FVC mean, % pred. (SD) | 83 (16)* |
FEV1/FVC, %, mean (SD) | 84 (9)* |
